Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/aor.13801 http://scihub22266oqcxt.onion/10.1111/aor.13801 33098217!ä!33098217 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Artif+Organs 2020 ; 44 (11): 1135-1149 Nephropedia Template TP {{tp|p=33098217|t=2020. Artificial lungs--Where are we going with the lung replacement therapy?|pdf=|usr=}}{{33098217}} gab.com Text Artificial lungs--Where are we going with the lung replacement therapy JO: Artif Organs http://www.kidney.de/pget.php?&tw=1&pmid=33098217 #FOAvip Lung transplantation may be a final destination therapy in lung failure, but limited donor organ availability creates a need for alternative management, including artificial lung technology. This invited review discusses ongoing developments and future research pathways for respiratory assist devices and tissue engineering to treat advanced and refractory lung disease. An overview is also given on the aftermath of the coronavirus disease 2019 pandemic and lessons learned as the world comes out of this situation. The first order of business in the future of lung support is solving the problems with existing mechanical devices. Interestingly, challenges identified during the early days of development persist today. These challenges include device-related infection, bleeding, thrombosis, cost, and patient quality of life. The main approaches of the future directions are to repair, restore, replace, or regenerate the lungs. Engineering improvements to hollow fiber membrane gas exchangers are enabling longer term wearable systems and can be used to bridge lung failure patients to transplantation. Progress in the development of microchannel-based devices has provided the concept of biomimetic devices that may even enable intracorporeal implantation. Tissue engineering and cell-based technologies have provided the concept of bioartificial lungs with properties similar to the native organ. Recent progress in artificial lung technologies includes continued advances in both engineering and biology. The final goal is to achieve a truly implantable and durable artificial lung that is applicable to destination therapy. Twit Text FOAVip Artificial lungs--Where are we going with the lung replacement therapy ????Artif Organs http://www.kidney.de/pget.php?&tw=1&pmid=33098217 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33098217 #FOAvip English Wikipedia <ref>{{Cite pmid|33098217}}</ref> Artificial lungs--Where are we going with the lung replacement therapy? #MMPMID33098217 Swol J; Shigemura N; Ichiba S; Steinseifer U; Anraku M; Lorusso R Artif Organs 2020[Nov]; 44 (11): 1135-1149 PMID33098217show ga Lung transplantation may be a final destination therapy in lung failure, but limited donor organ availability creates a need for alternative management, including artificial lung technology. This invited review discusses ongoing developments and future research pathways for respiratory assist devices and tissue engineering to treat advanced and refractory lung disease. An overview is also given on the aftermath of the coronavirus disease 2019 pandemic and lessons learned as the world comes out of this situation. The first order of business in the future of lung support is solving the problems with existing mechanical devices. Interestingly, challenges identified during the early days of development persist today. These challenges include device-related infection, bleeding, thrombosis, cost, and patient quality of life. The main approaches of the future directions are to repair, restore, replace, or regenerate the lungs. Engineering improvements to hollow fiber membrane gas exchangers are enabling longer term wearable systems and can be used to bridge lung failure patients to transplantation. Progress in the development of microchannel-based devices has provided the concept of biomimetic devices that may even enable intracorporeal implantation. Tissue engineering and cell-based technologies have provided the concept of bioartificial lungs with properties similar to the native organ. Recent progress in artificial lung technologies includes continued advances in both engineering and biology. The final goal is to achieve a truly implantable and durable artificial lung that is applicable to destination therapy. |COVID-19/therapy[MESH] |Extracorporeal Membrane Oxygenation/*instrumentation[MESH] |Humans[MESH] |Intensive Care, Neonatal[MESH] |Oxygenators/*trends[MESH] |Tissue Engineering[MESH]Artificial lungs--Where are we going with the lung replacement therapy(epmc).pdf DeepDyve Pubget Overpricing